
Bio Protocol has unveiled OpenLabs, a comprehensive platform that merges AI-assisted research development, community crowdfunding, and on-chain governance. This move aims to bypass traditional grant gatekeepers, offering a streamlined alternative for scientific projects. The protocol’s ecosystem has already raised over $33 million through its BIO Genesis initiative.
Announced on June 19 during DeSci.Berlin 2026, OpenLabs allows researchers to develop ideas, collaborate with contributors, and secure funding within a single interface. Instead of navigating separate grant applications, governance platforms, and collaboration tools, users can leverage AI-driven workflows to refine their proposals and seek community approval through token-holder voting.
Bio Protocol emphasizes that this model replaces lengthy review cycles and institutional oversight common in traditional funding. Community members vote on research proposals, with BIO tokens serving as the governance and utility asset. The platform also integrates AI to assist in developing and polishing projects.
Two initial projects highlighted are RheumaAI, an AI agent for rheumatology research, and PeptAI, focused on peptide discovery. OpenLabs builds on Bio Protocol’s broader decentralized science strategy, which includes tokenized intellectual property and BioDAOs to direct funds toward biotechnology and scientific research.
Earlier efforts include the August 2025 launch of Aubrai, a decentralized BioAgent developed with VitaDAO for longevity research. Aubrai functions as an on-chain AI co-scientist, generating hypotheses and aiding in lab experiment design. Despite these advances, the BIO token has seen an 8% decline in the past 24 hours, reflecting broader market pressures and uncertainty around federal policies.
While decentralized science offers transparent funding and community participation, regulatory challenges remain. Tokenized IP in biotechnology intersects with securities laws, patent frameworks, and pharmaceutical oversight, which could complicate compliance as projects mature.